The company just had a major derisking event that nobody is talking about.Rare materials and magnet stocks are among the most talked-about stocks on the market today. Stocks like USA Rare Earth (USAR 2.18%) and MP Materials (MP 1.41%) have caught investors' attention this year as they offer the U.S. a secure domestic supply of materials and products essential to the modern economy. That's a critical consideration given the ongoing trade conflict and China's dominance of the industry.With that in mind, here' ...

Relmada Therapeutics (RLMD) is a clinical-stage pharma company with no commercialized products and a $141 million market cap. RLMD has shown strong technical momentum, gaining 440% since August. Shares have a 100% “Buy” technical opinion from Barchart. Despite technical strength, RLMD lacks revenue, faces pipeline setbacks, and is rated “Hold” on Wall Street. Author’s Note: Investments are judged by revenue, earnings, cash flow, and dividends – that’s Investing 101. This company was founded in 200 ...